Helen Frankenthaler Foundation

Benzyl glycine hydrochloride CAS NO.2462-31-9

Etelcalcetide (hydrochloride) (CAS 1334237-71-6)

Etelcalcetide (hydrochloride)

Etelcalcetide (hydrochloride) (KAI 4169, Velcalcetide, CAS Number: 1334237-71-6) | Cayman Chemical

Technical Information

Formal Name: N-acetyl-D-cysteinyl-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-alanyl-D-argininamide, disulfide with L-cysteine, hydrochloride

CAS Number: 1334237-71-6

Synonyms
  • KAI 4169
  • Velcalcetide

Molecular Formula: C 38 H 73 N 21 O 10 S 2 • XHCl

Formula Weight: 1048.3

Purity: ≥95%

Formulation: A crystalline solid

Solubility

DMSO: 10 mg/ml PBS (pH 7.2): 10 mg/ml

SMILES: O=C([C@H](NC([C@H](NC([C@H](NC([C@@H](CSSC[C@@H](C(O)=O)N)NC(C)=O)=O)C)=O)CCCNC(N)=N)=O)CCCNC(N)=N)N[C@@H](C(N[C@@H](C(N[C@H](CCCNC(N)=N)C(N)=O)=O)C)=O)CCCNC(N)=N.Cl

InChi Code: InChI=1S/C38H73N21O10S2.ClH/c1-18(28(62)56-22(27(40)61)8-4-12-49-35(41)42)53-30(64)23(9-5-13-50-36(43)44)58-32(66)25(11-7-15-52-38(47)48)59-31(65)24(10-6-14-51-37(45)46)57-29(63)19(2)54-33(67)26(55-20(3)60)17-71-70-16-21(39)34(68)69;/h18-19,21-26H,4-17,39H2,1-3H3,(H2,40,61)(H,53,64)(H,54,67)(H,55,60)(H,56,62)(H,57,63)(H,58,66)(H,59,65)(H,68,69)(H4,41,42,49)(H4,43,44,50)(H4,45,46,51)(H4,47,48,52);1H/t18-,19-,21+,22-,23-,24-,25-,26-;/m1./s1

InChi Key: KHQMSZGKHGQUHG-WZDHWKSBSA-N

Shipping & Storage Information

Storage: -20°C

Shipping: Room temperature in continental US; may vary elsewhere

Product Description

Etelcalcetide is a peptide agonist of the calcium-sensing receptor (CaSR). It is selective for CaSR over a panel of 33 receptors and ion channels, as well as the norepinephrine transporter at 10 µM. Etelcalcetide increases intracellular calcium levels in HEK293T cells expressing the human CaSR receptor with an EC 50 value of 0.53 µM. It also inhibits parathyroid secretion from primary rat parathyroid cells (EC 50 = 0.36 µM in the presence of calcium). Etelcalcetide (0.3, 1, and 3 mg/kg) decreases parathyroid hormone and calcium levels in plasma and serum, respectively, in a model of chronic renal insufficiency with secondary hyperthyroidism in nephrectomized rats fed a high-phosphorus diet. Formulations containing etelcalcetide have been used in the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease undergoing hemodialysis.

WARNING This product is not for human or veterinary use.

References & Product Citations

Product Description References

1. Harada, K., Fujioka, A., Konno, M., et al.Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients. Eur. J. Pharmacol. 842, 139-145 (2019).